Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-03-01 Morrison Briggs Chief Executive Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2018-03-01 Meyers Michael L. SVP, Chief Medical Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2018-03-01 Metzger Michael A President and COO Grant or award · Stock Option (Right to Buy) +125,000 125,000
2018-02-08 Podlesak Dennis Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2018-02-08 Legault Pierre Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2018-02-08 Katkin Keith Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2018-02-08 EVNIN LUKE Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2018-02-08 Egros Fabrice Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2018-02-08 Chen Henry Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-05-17 Ordentlich Peter Chief Scientific Officer Option exercise +732 $3.08 $2K 5,000
2017-05-17 Ordentlich Peter Chief Scientific Officer Sale −5,000 $15.00 $75K 0
2017-05-17 Ordentlich Peter Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) −732 0
2017-05-17 Sledge George W. Jr. Director Grant or award · Stock Options (Right to buy) +5,000 5,000
2017-05-17 Podlesak Dennis Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-05-17 Podlesak Dennis Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2017-05-17 Legault Pierre Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-05-17 Legault Pierre Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2017-05-17 Katkin Keith Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-05-17 EVNIN LUKE Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-05-17 EVNIN LUKE Director Grant or award · Stock Option (Right to Buy) +5,000 5,000

Page 25 of 25 · 500 trades